Does Altamira Therapeutics Ltd (NASDAQ:CYTO) warrant a purchase right now? What to Consider Before Making a Decision
Altamira Therapeutics Ltd (NASDAQ:CYTO) shares traded -53.79% lower at $0.19 on Wall Street last session. In accordance with the data, 1 analysts cover Altamira Therapeutics Ltd (NASDAQ:CYTO). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $286.10 and a low of $286.10, […]
The shares of Altamira Therapeutics Ltd (CYTO) have recorded the market capitalization of 3.20M
The stock of Altamira Therapeutics Ltd (NASDAQ:CYTO) last traded at $0.36, up 18.92% from the previous session. Data from the available sources indicates that Altamira Therapeutics Ltd (NASDAQ:CYTO) is covered by 1 analysts. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of […]
A secret that hides Altamira Therapeutics Ltd’s strength (NASDAQ:CYTO)
Stocks of Altamira Therapeutics Ltd (NASDAQ:CYTO) traded higher last session on Wall Street, down -6.35% to $0.28. According to the data, Altamira Therapeutics Ltd (NASDAQ:CYTO) has 1 analysts covering its stock. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $286.10 and […]
There is little time left for Altamira Therapeutics Ltd (CYTO) to reach its 1-year target estimate. How soon will it surpass it?
Altamira Therapeutics Ltd (NASDAQ:CYTO) shares traded 14.29% higher at $0.32 on Wall Street last session. In accordance with the data, 1 analysts cover Altamira Therapeutics Ltd (NASDAQ:CYTO). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $286.10 and a low of $286.10, […]
Stocks like Altamira Therapeutics Ltd [CYTO] still have plenty of sunny days ahead
In yesterday’s Wall Street session, Altamira Therapeutics Ltd (NASDAQ:CYTO) shares traded at $0.11, down -11.25% from the previous session. As of this writing, 1 analysts cover Altamira Therapeutics Ltd (NASDAQ:CYTO). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $286.10 and a […]
